SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011699
Filing Date
2024-03-28
Accepted
2024-03-28 14:35:14
Documents
78
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1413759
2 ex4-5.htm EX-4.5 38164
3 ex31-1.htm EX-31.1 17714
4 ex31-2.htm EX-31.2 17845
5 ex32.htm EX-32 6379
  Complete submission text file 0001493152-24-011699.txt   6618987

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pvct-20231231.xsd EX-101.SCH 53575
7 XBRL CALCULATION FILE pvct-20231231_cal.xml EX-101.CAL 63154
8 XBRL DEFINITION FILE pvct-20231231_def.xml EX-101.DEF 195584
9 XBRL LABEL FILE pvct-20231231_lab.xml EX-101.LAB 395366
10 XBRL PRESENTATION FILE pvct-20231231_pre.xml EX-101.PRE 311330
81 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1058152
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36457 | Film No.: 24797797
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)